India · Delayed Price · Currency is INR AstraZeneca Pharma India Statistics
Total Valuation
NSE:ASTRAZEN has a market cap or net worth of INR 214.97 billion. The enterprise value is 211.32 billion.
| Market Cap | 214.97B |
| Enterprise Value | 211.32B |
Important Dates
The last earnings date was Wednesday, February 11, 2026.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | Jul 18, 2025 |
Share Statistics
| Current Share Class | 25.00M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.04% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 6.18% |
| Owned by Institutions (%) | 8.09% |
| Float | 4.60M |
Valuation Ratios
The trailing PE ratio is 107.01.
| PE Ratio | 107.01 |
| Forward PE | n/a |
| PS Ratio | 9.87 |
| PB Ratio | 26.91 |
| P/TBV Ratio | 26.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 105.19 |
| EV / Sales | 9.70 |
| EV / EBITDA | 69.83 |
| EV / EBIT | 85.33 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | n/a |
| Interest Coverage | 79.12 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 42.08% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.10% |
| Revenue Per Employee | 36.29M |
| Profits Per Employee | 3.35M |
| Employee Count | 600 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:ASTRAZEN has paid 716.40 million in taxes.
| Income Tax | 716.40M |
| Effective Tax Rate | 26.29% |
Stock Price Statistics
The stock price has increased by +10.27% in the last 52 weeks. The beta is 0.15, so NSE:ASTRAZEN's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | +10.27% |
| 50-Day Moving Average | 8,627.14 |
| 200-Day Moving Average | 8,963.16 |
| Relative Strength Index (RSI) | 43.20 |
| Average Volume (20 Days) | 6,101 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ASTRAZEN had revenue of INR 21.77 billion and earned 2.01 billion in profits. Earnings per share was 80.38.
| Revenue | 21.77B |
| Gross Profit | 9.26B |
| Operating Income | 2.48B |
| Pretax Income | 2.73B |
| Net Income | 2.01B |
| EBITDA | 2.98B |
| EBIT | 2.48B |
| Earnings Per Share (EPS) | 80.38 |
Balance Sheet
The company has 4.00 billion in cash and 347.90 million in debt, with a net cash position of 3.65 billion.
| Cash & Cash Equivalents | 4.00B |
| Total Debt | 347.90M |
| Net Cash | 3.65B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 7.99B |
| Book Value Per Share | 319.63 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 42.52%, with operating and profit margins of 11.37% and 9.23%.
| Gross Margin | 42.52% |
| Operating Margin | 11.37% |
| Pretax Margin | 12.52% |
| Profit Margin | 9.23% |
| EBITDA Margin | 13.67% |
| EBIT Margin | 11.37% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 32.00, which amounts to a dividend yield of 0.36%.
| Dividend Per Share | 32.00 |
| Dividend Yield | 0.36% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 4 |
| Payout Ratio | n/a |
| Buyback Yield | 0.04% |
| Shareholder Yield | 0.40% |
| Earnings Yield | 0.93% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |